Towards the elaboration of new gold-based optical theranostics

Pierre-Emmanuel Doulain1, Richard Decréau, Cindy Racoeur

  • 1Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302 CNRS, Université de Bourgogne, 9 avenue Alain Savary, BP 47870, 21080 Dijon Cedex, France. ewen.bodio@u-bourgogne.fr christine.goze@u-bourgogne.fr.

Insights

Four novel red BODIPY-gold(I) theranostic compounds were synthesized and functionalized with biovectors. These compounds show potential for cancer theranostics, with evaluated photophysical, cytotoxic, and cellular uptake properties.

Area of Science:

  • Medicinal Chemistry
  • Nanotechnology
  • Biomedical Imaging

Background:

  • Theranostics combine therapy and diagnostics for personalized medicine.
  • BODIPY dyes and gold(I) complexes offer unique photophysical and therapeutic properties.
  • Targeted drug delivery enhances therapeutic efficacy and reduces side effects.

Purpose of the Study:

  • To synthesize and characterize novel red BODIPY-gold(I) theranostic compounds.
  • To investigate the impact of biovector conjugation (glucose, bombesin) on compound properties.
  • To evaluate the potential of these compounds for cancer theranostic applications.

Main Methods:

  • Synthesis of four new red BODIPY-gold(I) complexes.
  • Vectorization of complexes with glucose or bombesin derivatives.
  • Photophysical characterization (absorption, emission spectra).
  • In vitro cytotoxicity assays on cancer and normal cell lines.
  • Cellular uptake studies using fluorescence microscopy and ICP-MS.

Main Results:

  • Successful synthesis of four novel red BODIPY-gold(I) compounds.
  • Demonstrated photophysical properties suitable for imaging and therapy.
  • Differential cytotoxicity observed across various cancer cell lines.
  • Evidence of cellular uptake and localization, influenced by biovectorization.
  • ICP-MS confirmed gold accumulation in cells.

Conclusions:

  • The synthesized BODIPY-gold(I) compounds exhibit promising theranostic potential.
  • Biovectorization can enhance targeted cellular uptake and efficacy.
  • These compounds represent a new class of agents for cancer theranostics.
  • Further in vivo studies are warranted to explore their full therapeutic and diagnostic capabilities.